Category: Clinical Breakthroughs
-
Genomic Autopsy Identifies Cardiomyopathy Variants
Genomic autopsy of young individuals who experienced sudden death revealed many had known genetic variants that are associated with cardiomyopathy.
-
Advancing Quality Improvement to Boost Health Equity
Quality improvement must measure more than average care quality and change to address the root causes of health inequity, according to a Northwestern Medicine editorial published in The BMJ.
-
‘Alarming’ Rise in Gestational Diabetes in U.S.
The rate of gestational diabetes has shot up 30 percent in young U.S. women over the past decade according to a new Northwestern Medicine study.
-
Using Circulating Tumor DNA to Target Immunotherapy
Using circulating tumor DNA to identify patients at risk for urothelial cancer relapse after surgical resection could help improve post-surgery treatment, according to a new study.
-
Combined Therapy Shows Promise for Chronic Lymphocytic Leukemia
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia, according to a Northwestern Medicine clinical trial.
-
Novel Therapy May Improve Survival for Malignant Gliomas
A novel therapy developed by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, the most common primary brain tumors in adults.
-
Virtual Intervention Reduces Fear of Breast Cancer Recurrence
A targeted virtual health intervention was effective in reducing fear of recurrence among breast cancer survivors.
-
Evaluating Esophageal Hypervigilance and Symptom Anxiety
Measuring levels of hypervigilance and anxiety may improve healthcare providers’ understanding of severe esophageal diseases and treatment strategies, according to a Northwestern Medicine study.
-
Novel Treatments to Prevent Infections in Patients with Leukemia
Using universal myeloid progenitor cells or modified umbilical cord blood may help prevent infections in patients with leukemia, according to a pair of recent studies.
-
Anti-Seizure Medication Exposure in Pregnancy Doesn’t Harm Child’s Cognitive Outcomes
Children born to women with epilepsy who took anti-seizure medications during pregnancy versus children born to women without epilepsy did not differ in terms of cognitive outcomes and overall neurodevelopment, according to findings published in JAMA Neurology.
